Literature DB >> 30466606

Rhein protects the myocardiac cells against hypoxia/reoxygention-induced injury by suppressing GSK3β activity.

Jing Liu1, Yanming Li1, Yi Tang1, Jinghua Cheng1, Jing Wang1, Jianhua Li1, Xiaohua Ma1, Wei Zhuang1, Jianbin Gong2, Zhihong Liu3.   

Abstract

BACKGROUND: Rhein, an anthraquinone compound isolated from rhubarb, has been shown to protect the pancreatic β cells from hyperglycemia induced apoptosis in our previous studies.
PURPOSE: In the present study, we examined whether rhein can protect myocardial cells against ischemia reperfusion (I/R)-induced apoptosis and investigated the underlying mechanism.
METHODS: We used an in vitro model of myocardial hypoxia/reoxygenation (H/R) injury. H9c2 cells were incubated with rhein for 1 h and then subjected to hypoxia for 6 h, followed by reoxygenation for 2 h. Cells viability, apoptosis and ROS were assayed for the treated cells. AKT, p-AKT, GSK3β, p- GSK3β, P38 and p-P38 proteins were analyzed using Western blotting. PI3K/AKT inhibitor, LY294002, and GSK3β siRNA were also used to determine the signaling pathways involved in the protection by rhein.
RESULTS: Rhein increased viability, decreased apoptosis and ROS production, of the cells that were exposed to H/R. Rhein also increased the phosphorylation of AKT and GSK3β, an effect that was eliminated by LY294002. GSK3β silencing by siRNA showed similar effect as LY294002. The p-P38 level was upregulated by H/R and downregulated in the presence of rhein; however, the p-P38 downregulation was completely abolished by GSK3β silencing.
CONCLUSION: Rhein protects myocardial H9c2 cells against hypoxia/reoxygenation induced injury via AKT/ GSK3β/p38 pathway.
Copyright © 2018. Published by Elsevier GmbH.

Entities:  

Keywords:  H9c2 cells; Hypoxia/reoxygenation; Myocardial cells; PI3K/AKT; Rhein

Mesh:

Substances:

Year:  2018        PMID: 30466606     DOI: 10.1016/j.phymed.2018.06.029

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  9 in total

1.  Rhein attenuates angiotensin II-induced cardiac remodeling by modulating AMPK-FGF23 signaling.

Authors:  Wei Lu; Hongqiao Zhu; Jiawen Wu; Sheng Liao; Guobing Cheng; Xiaoyang Li
Journal:  J Transl Med       Date:  2022-07-06       Impact factor: 8.440

Review 2.  Crosstalk between GSK-3β-actuated molecular cascades and myocardial physiology.

Authors:  Arun K Sharma; Saurabh Bhatia; Ahmed Al-Harrasi; Mukesh Nandave; Hanan Hagar
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

3.  Prokineticin 2 (PK2) Rescues Cardiomyocytes from High Glucose/High Palmitic Acid-Induced Damage by Regulating the AKT/GSK3β Pathway In Vitro.

Authors:  Zhen Yang; Yin Wu; Linge Wang; Peng Qiu; Wenliang Zha; Wei Yu
Journal:  Oxid Med Cell Longev       Date:  2020-05-18       Impact factor: 6.543

Review 4.  An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2.

Authors:  Roodabeh Bahramsoltani; Roja Rahimi
Journal:  Front Pharmacol       Date:  2020-11-25       Impact factor: 5.810

5.  Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis.

Authors:  Yu Bian; Xin Li; Ping Pang; Xue-Ling Hu; Shu-Ting Yu; Yi-Ning Liu; Xin Li; Ning Wang; Jin-Hui Wang; Wei Xiao; Wei-Jie Du; Bao-Feng Yang
Journal:  Acta Pharmacol Sin       Date:  2019-10-23       Impact factor: 6.150

6.  Rhein ameliorates transverse aortic constriction-induced cardiac hypertrophy via regulating STAT3 and p38 MAPK signaling pathways.

Authors:  Run-Jing Li; Jia-Jia Xu; Zheng-Hao Zhang; Min-Wei Chen; Shi-Xiao Liu; Cui Yang; Yan-Ling Li; Ping Luo; Yi-Jiang Liu; Rong Tang; Zhong-Gui Shan
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

7.  Downregulation of Cypher induces apoptosis in cardiomyocytes via Akt/p38 MAPK signaling pathway.

Authors:  Tianming Xuan; Dongfei Wang; Jialan Lv; Zhicheng Pan; Juan Fang; Yin Xiang; Hongqiang Cheng; Xingxiang Wang; Xiaogang Guo
Journal:  Int J Med Sci       Date:  2020-08-27       Impact factor: 3.738

Review 8.  Chinese medicinal plants for the potential management of high-altitude pulmonary oedema and pulmonary hypertension.

Authors:  Tingting Wang; Jun Hou; Wenjing Xiao; Yaolei Zhang; Longfu Zhou; Li Yuan; Xiaoqiang Yin; Xin Chen; Yonghe Hu
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

9.  Diacerein: A potential multi-target therapeutic drug for COVID-19.

Authors:  Pedro Gonçalves de Oliveira; Lara Termini; Edison Luiz Durigon; Ana Paula Lepique; Andrei C Sposito; Enrique Boccardo
Journal:  Med Hypotheses       Date:  2020-06-01       Impact factor: 1.538

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.